相关实验视频

Updated: Jan 11, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

LT1-3是一种Slit2衍生的,表现出抗瘤活性,并改善了西斯普拉丁治疗

Ting-Chien Wu¹, Chen-Yi Liao¹, Yu-Ying Lin²

¹Institute of Medicine, Chung Shan Medical University, 110, Sec. 1, Chien-Kuo N. Road, Taichung City 402306, Taiwan.

|November 13, 2025

概括

从Slit2中获得的一种新,LT1-3,可以抑制肺癌的生长和侵袭,而不会伤害正常细胞. 它与西斯普拉丁协同作用,为肺癌提供了一个有前途的新疗法,特别是在TP53突变瘤中.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症信号通路癌症信号通路

背景情况:

Slit2/Robo路径是众所周知的各种癌症中的瘤抑制剂.
针对癌细胞的扩散和入侵对于有效的治疗至关重要.

研究的目的:

鉴定和描述一种新型,LT1-3,由Slit2衍生,其抗肺癌特性.
在临床前肺癌模型中评估LT1-3的疗效,单独或与西斯普拉丁结合.

主要方法:

来自Slit2 LamG域的8-氨基酸 (LT1-3) 的鉴定.
在体外测试评估肺癌细胞系中的扩散和侵入抑制.
在体内研究使用带有瘤的免疫缺陷裸体小鼠.
在LT1-3反应中分析TP53,MAPK8 (JNK1) 和PRKACA (PKA) 的作用.

主要成果:

LT1-3抑制了肺癌细胞的增殖和侵袭,独立于机器人受体,对正常细胞无毒.
在小鼠中,与LT1-3和西斯普拉丁的联合治疗显示出协同作用的抗增殖作用和延长生存时间.
TP53对LT1-3的疗效产生了积极的影响,而MAPK8和PRKACA则充当了负面的调节者;JNK抑制和APR-246在特定的突变环境中恢复了敏感性.

结论:

LT1-3表现出强大的,多功能抗瘤特性,可以对抗肺癌.
即使存在TP53突变,LT1-3也提高了西斯的疗效,这表明它具有广泛的适用性.
使用LT1-3和西斯普拉丁的联合治疗是一种有前途的肺癌第一线治疗策略.

关键词:

美国人民币2466.西斯普拉丁 (Cisplatin) 是一种这就是JNK1的原因.在LT1-31-3中,我们可以使用这是一个Slit2Slit2Slit.在 p53 里,p53 是一个 p53 的代码.

更多相关视频

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...